Killer T Cell: The Cancer Assassin

Fighting cancer: Animal research at Cambridge

Animal research plays an essential role in our understanding of health and disease and in the development of modern medicine and surgical techniques. As part of our commitment to openness, this film examines how mice are helping the fight against cancer. It takes a in-depth look at the faci ... more

The Super-Resolution Revolution

Cambridge scientists are part of a resolution revolution. Building powerful instruments that shatter the physical limits of optical microscopy, they are beginning to watch molecular processes as they happen, and in three dimensions. Here, Professor Clemens Kaminski describes how a new era o ... more

PARP-inhibitors: A New Generation of Cancer Drugs

First of new generation of cancer drugs granted European approvalA new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The dr ... more

Formation of quadruple helix DNA tracked in live human cells for the first time

The formation of four-stranded DNA has been tracked in living human cells, allowing scientists to see how it works, and its possible role in cancer. DNA usually forms the classic double helix shape discovered in 1953 - two strands wound around each other. Several other structures have been ... more

Scientists produce first open source all-atom models of full-length COVID-19 'S' protein

The virus SARS coronavirus 2 (SARS-CoV-2) is the known cause of coronavirus disease 2019 (COVID-19). The "spike" or S protein facilitates viral entry into host cells. Now a group of researchers from Seoul National University in South Korea, University of Cambridge in UK, and Lehigh Universi ... more

Nanoparticles used to transport anti-cancer agent to cells

Scientists from the University of Cambridge have developed a platform that uses nanoparticles known as metal-organic frameworks to deliver a promising anti-cancer agent to cells. Research led by Dr David Fairen-Jimenez, from the Cambridge Department of Chemical Engineering and Biotechnology ... more